The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?
Activity: Talk or presentation types › Lecture and oral contribution
Timo Minssen - Lecturer
- Faculty of Law Research Centres
- Centre for Information and Innovation Law
This presentation will discuss the most recent developments relating to the “industrial application” requirement with a special emphasis on gene and protein-related inventions in Europe. In addition to providing a brief overview of the applicable legislative framework, this presentation will address relevant EPO practice and the UK Supreme Court’s seminal decision in HGS v Eli Lilly.
12 Aug 2013
Event (Course)
| Title | Pharmaceutical Law & Policy- Hot topics shaping the future of the pharma industry |
|---|---|
| Abbreviated title | CSU 2013 |
| Date | 12/08/2013 → 16/08/2013 |
| Location | Frederiksberg Campus |
| City | Copenhagen |
| Country/Territory | Denmark |
Related Research outputs (1)
- Published
The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?"
Research output: Contribution to journal › Journal article › Research › peer-review
ID: 49702634